1997年至2006年期间，西班牙马德里脆弱拟杆菌群的耐药趋势。
Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.
作者信息
Betriu Carmen, Culebras Esther, Gómez María, López Fátima, Rodríguez-Avial Iciar, Picazo Juan J
机构信息
Servicio de Microbiología Clínica, Hospital Clínico San Carlos, Plaza Cristo Rey s/n, 28040 Madrid, Spain.
出版信息
Antimicrob Agents Chemother. 2008 Jul;52(7):2686-90. doi: 10.1128/AAC.00081-08. Epub 2008 May 12.
Abstract
The changes in susceptibilities of Bacteroides fragilis group strains isolated in our hospital from 1997 to 2006 were studied. A total of 1,343 clinical strains were included. The study showed differences in the resistance rates in the different species of the group. Increasing resistance to clindamycin and moxifloxacin was observed. Susceptibility to imipenem, piperacillin-tazobactam, and metronidazole remained unchanged.
摘要
我们对1997年至2006年我院分离出的脆弱拟杆菌群菌株的药敏变化进行了研究。共纳入1343株临床菌株。研究显示该菌群不同菌种的耐药率存在差异。观察到对克林霉素和莫西沙星的耐药性增加。对亚胺培南、哌拉西林-他唑巴坦和甲硝唑的敏感性保持不变。
相似文献
1
Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.1997年至2006年期间，西班牙马德里脆弱拟杆菌群的耐药趋势。
Antimicrob Agents Chemother. 2008 Jul;52(7):2686-90. doi: 10.1128/AAC.00081-08. Epub 2008 May 12.
2
[Evolution of the sensitivity of Bacteroides group fragilis at the Sevilla University Hospital (1983-1987)].[塞维利亚大学医院脆弱拟杆菌属的敏感性演变（1983 - 1987年）]
Enferm Infecc Microbiol Clin. 1991 Apr;9(4):214-8.
3
Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.1990年至1994年间脆弱拟杆菌群临床分离株抗菌药物耐药模式的趋势分析。
Clin Infect Dis. 1996 Dec;23 Suppl 1:S54-65. doi: 10.1093/clinids/23.supplement_1.s54.
4
First national survey of antibiotic susceptibility of the Bacteroides fragilis group: emerging resistance to carbapenems in Argentina.首个关于脆弱拟杆菌群抗生素敏感性的全国性调查：阿根廷出现碳青霉烯类耐药。
Antimicrob Agents Chemother. 2012 Mar;56(3):1309-14. doi: 10.1128/AAC.05622-11. Epub 2012 Jan 9.
5
Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.来自阿根廷布宜诺斯艾利斯的脆弱拟杆菌群分离株的药敏趋势。
Rev Argent Microbiol. 2007 Jul-Sep;39(3):156-60.
6
Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).从厌氧菌调查中吸取的教训：历史透视和对最新数据（2005-2007 年）的回顾。
Clin Infect Dis. 2010 Jan 1;50 Suppl 1:S26-33. doi: 10.1086/647940.
7
Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.1997年至2004年韩国8年间脆弱拟杆菌群的耐药趋势
Korean J Lab Med. 2009 Aug;29(4):293-8. doi: 10.3343/kjlm.2009.29.4.293.
8
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience.欧洲脆弱拟杆菌群分离株的抗菌药敏性：20 年的经验。
Clin Microbiol Infect. 2011 Mar;17(3):371-9. doi: 10.1111/j.1469-0691.2010.03256.x.
9
In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data.脆弱拟杆菌群菌种的体外药敏：分离率的变化显著影响总体药敏数据。
J Clin Microbiol. 2002 Nov;40(11):4349-52. doi: 10.1128/JCM.40.11.4349-4352.2002.
10
Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance study.2010-2011 年加拿大脆弱拟杆菌群临床分离株的抗菌药物耐药性流行情况：CANWARD 监测研究。
Antimicrob Agents Chemother. 2012 Mar;56(3):1247-52. doi: 10.1128/AAC.05823-11. Epub 2011 Dec 27.
引用本文的文献
1
Phenotypic and Genotypic Correlation of Antimicrobial Susceptibility of Bacteroides fragilis: Lessons Learnt.脆弱拟杆菌药敏性的表型与基因型相关性：经验教训
Cureus. 2023 Mar 16;15(3):e36268. doi: 10.7759/cureus.36268. eCollection 2023 Mar.
2
Repositioning small molecule drugs as allosteric inhibitors of the BFT-3 toxin from enterotoxigenic Bacteroides fragilis.将小分子药物重新定位为肠毒素脆弱拟杆菌 BFT-3 毒素的别构抑制剂。
Protein Sci. 2022 Oct;31(10):e4427. doi: 10.1002/pro.4427.
3
Antibiotic Resistance and Mechanisms of Pathogenic Bacteria in Tubo-Ovarian Abscess.输卵管卵巢脓肿中病原菌的耐药性及机制
Front Cell Infect Microbiol. 2022 Jul 27;12:958210. doi: 10.3389/fcimb.2022.958210. eCollection 2022.
4
Bloodstream infection caused by in a patient with renal hypertension: a case report.血液感染由 引起的患者肾性高血压：一例报告。
J Int Med Res. 2021 Oct;49(10):3000605211047277. doi: 10.1177/03000605211047277.
5
Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Rubik's Cube of Clinical Microbiology?厌氧菌的鉴定及药敏试验：临床微生物学的魔方？
Antibiotics (Basel). 2017 Nov 7;6(4):25. doi: 10.3390/antibiotics6040025.
6
Five-year retrospective epidemiological survey of anaerobic bacteraemia in a university hospital and rewiew of the literature.某大学医院厌氧菌血症的五年回顾性流行病学调查及文献综述
Eur J Microbiol Immunol (Bp). 2012 Jun;2(2):140-7. doi: 10.1556/EuJMI.2.2012.2.7. Epub 2012 Jun 13.
7
Distribution, detection of enterotoxigenic strains and antimicrobial drug susceptibility patterns of bacteroides fragilis group in diarrheic and non-diarrheic feces from brazilian infants.巴西婴幼儿腹泻和非腹泻粪便中产脆弱拟杆菌群的分布、肠毒素产生菌株的检测及抗菌药物敏感性模式。
Braz J Microbiol. 2010 Jul;41(3):603-11. doi: 10.1590/S1517-83822010000300010. Epub 2010 Sep 1.
8
Global fluoroquinolone resistance epidemiology and implictions for clinical use.全球氟喹诺酮类药物耐药性流行病学及其临床应用意义
Interdiscip Perspect Infect Dis. 2012;2012:976273. doi: 10.1155/2012/976273. Epub 2012 Oct 14.
9
Mobile genetic elements in the genus Bacteroides, and their mechanism(s) of dissemination.拟杆菌属中的可移动遗传元件及其传播机制。
Mob Genet Elements. 2011 Sep;1(3):187-196. doi: 10.4161/mge.1.3.18448. Epub 2011 Sep 1.
10
In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics.克林霉素、亚胺培南、甲硝唑和哌拉西林-他唑巴坦对脆弱拟杆菌敏感和耐药分离株的体外活性评价——通过杀菌动力学。
Antimicrob Agents Chemother. 2012 Jun;56(6):3413-6. doi: 10.1128/AAC.00099-12. Epub 2012 Mar 19.
本文引用的文献
1
Reemergence of anaerobic bacteremia.厌氧菌血症的再度出现。
Clin Infect Dis. 2007 Apr 1;44(7):895-900. doi: 10.1086/512197. Epub 2007 Feb 14.
2
National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.脆弱拟杆菌群药敏全国调查：1997年至2004年美国趋势报告与分析
Antimicrob Agents Chemother. 2007 May;51(5):1649-55. doi: 10.1128/AAC.01435-06. Epub 2007 Feb 5.
3
Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria.比利时第三次厌氧菌抗生素敏感性多中心调查。
J Antimicrob Chemother. 2007 Jan;59(1):132-9. doi: 10.1093/jac/dkl458. Epub 2006 Nov 9.
4
In vitro activities of tigecycline against recently isolated Gram-negative anaerobic bacteria in Greece, including metronidazole-resistant strains.替加环素对希腊近期分离的革兰氏阴性厌氧菌（包括耐甲硝唑菌株）的体外活性。
Diagn Microbiol Infect Dis. 2006 Jul;55(3):231-6. doi: 10.1016/j.diagmicrobio.2006.01.022. Epub 2006 Apr 19.
5
Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002).1997年至2002年6年间脆弱拟杆菌属菌群中氟喹诺酮耐药模式的变化
Diagn Microbiol Infect Dis. 2005 Nov;53(3):221-3. doi: 10.1016/j.diagmicrobio.2005.06.012. Epub 2005 Oct 21.
6
Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.对包括厄他培南在内的七种抗菌药物针对希腊近期分离出的革兰氏阴性厌氧菌的体外活性进行的多中心调查。
Clin Microbiol Infect. 2005 Oct;11(10):820-4. doi: 10.1111/j.1469-0691.2005.01233.x.
7
In vitro activities of tigecycline against the Bacteroides fragilis group.替加环素对脆弱拟杆菌群的体外活性。
Antimicrob Agents Chemother. 2004 Mar;48(3):1034-6. doi: 10.1128/AAC.48.3.1034-1036.2004.
8
Emergence of fluoroquinolone resistance among Bacteroides species.拟杆菌属中氟喹诺酮耐药性的出现。
J Antimicrob Chemother. 2003 Aug;52(2):208-13. doi: 10.1093/jac/dkg320. Epub 2003 Jul 15.
9
Increase in resistance to new fluoroquinolones from 1998 to 2001 in the Bacteroides fragilis group.1998年至2001年间脆弱拟杆菌群对新型氟喹诺酮类药物耐药性的增加。
J Antimicrob Chemother. 2002 Dec;50(6):1055-7. doi: 10.1093/jac/dkf230.
10
High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.台湾厌氧菌中头孢西丁和克林霉素耐药性的高发生率。
Antimicrob Agents Chemother. 2002 Sep;46(9):2908-13. doi: 10.1128/AAC.46.9.2908-2913.2002.
Zotero 插件